These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21752185)
1. Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments. Yakovlev S; Gao Y; Cao C; Chen L; Strickland DK; Zhang L; Medved L J Thromb Haemost; 2011 Sep; 9(9):1847-55. PubMed ID: 21752185 [TBL] [Abstract][Full Text] [Related]
2. Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide. Yakovlev S; Cao C; Galisteo R; Zhang L; Strickland DK; Medved L Thromb Haemost; 2019 Nov; 119(11):1816-1826. PubMed ID: 31466086 [TBL] [Abstract][Full Text] [Related]
3. Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes. Yakovlev S; Mikhailenko I; Cao C; Zhang L; Strickland DK; Medved L Blood; 2012 Jan; 119(2):637-44. PubMed ID: 22096238 [TBL] [Abstract][Full Text] [Related]
4. Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. Bach TL; Barsigian C; Yaen CH; Martinez J J Biol Chem; 1998 Nov; 273(46):30719-28. PubMed ID: 9804847 [TBL] [Abstract][Full Text] [Related]
5. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-cadherin domain. Yakovlev S; Medved L Biochemistry; 2009 Jun; 48(23):5171-9. PubMed ID: 19413351 [TBL] [Abstract][Full Text] [Related]
6. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Gorlatov S; Medved L Biochemistry; 2002 Mar; 41(12):4107-16. PubMed ID: 11900554 [TBL] [Abstract][Full Text] [Related]
7. Dual functions of the fibrin βN-domains in the VLDL receptor-dependent pathway of transendothelial migration of leukocytes. Yakovlev S; Medved L Thromb Res; 2022 Jun; 214():1-7. PubMed ID: 35421681 [TBL] [Abstract][Full Text] [Related]
8. Identification of Neural (N)-Cadherin as a Novel Endothelial Cell Receptor for Fibrin and Localization of the Complementary Binding Sites. Yakovlev S; Tjandra N; Strickland DD; Medved L Biochemistry; 2024 Jan; 63(2):202-211. PubMed ID: 38156948 [TBL] [Abstract][Full Text] [Related]
9. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Petzelbauer P; Zacharowski PA; Miyazaki Y; Friedl P; Wickenhauser G; Castellino FJ; Gröger M; Wolff K; Zacharowski K Nat Med; 2005 Mar; 11(3):298-304. PubMed ID: 15723073 [TBL] [Abstract][Full Text] [Related]
11. Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation. Yakovlev S; Strickland DK; Medved L Thromb Haemost; 2022 Nov; 122(11):1858-1868. PubMed ID: 35896433 [TBL] [Abstract][Full Text] [Related]
12. Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site. Yakovlev S; Gorlatov S; Ingham K; Medved L Biochemistry; 2003 Jul; 42(25):7709-16. PubMed ID: 12820880 [TBL] [Abstract][Full Text] [Related]
13. Interaction of Fibrin with the Very Low-Density Lipoprotein (VLDL) Receptor: Further Characterization and Localization of the VLDL Receptor-Binding Site in Fibrin βN-Domains. Yakovlev S; Medved L Biochemistry; 2017 May; 56(19):2518-2528. PubMed ID: 28437098 [TBL] [Abstract][Full Text] [Related]
14. FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Ahrens I; Peter K Curr Opin Investig Drugs; 2009 Sep; 10(9):997-1003. PubMed ID: 19705343 [TBL] [Abstract][Full Text] [Related]
15. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction. Yan M; Zhang X; Chen A; Gu W; Liu J; Ren X; Zhang J; Wu X; Place AT; Minshall RD; Liu G FASEB J; 2017 Nov; 31(11):4759-4769. PubMed ID: 28701303 [TBL] [Abstract][Full Text] [Related]
16. Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al. Weijers EM; Koolwijk P; van Hinsbergh VW; van Nieuw Amerongen GP Int J Cancer; 2010 Dec; 127(12):2981-2; author reply 2982-6. PubMed ID: 21351277 [No Abstract] [Full Text] [Related]
17. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279 [TBL] [Abstract][Full Text] [Related]
18. Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes. Yakovlev S; Medved L Thromb Res; 2018 Feb; 162():93-100. PubMed ID: 29175090 [TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954 [TBL] [Abstract][Full Text] [Related]
20. Interaction of Fibrin with the Very Low Density Lipoprotein Receptor: Further Characterization and Localization of the Fibrin-Binding Site. Yakovlev S; Medved L Biochemistry; 2015 Aug; 54(30):4751-61. PubMed ID: 26153297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]